HC Wainwright reiterated their buy rating on shares of OmniAb (NASDAQ:OABI – Free Report) in a research note published on Thursday morning,Benzinga reports. The firm currently has a $11.00 price objective on the stock. A number of other equities research analysts also recently issued reports on OABI. Royal Bank of Canada restated an “outperform” rating […]

HC Wainwright reissued their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a report released on Tuesday morning,Benzinga reports. They currently have a $75.00 price objective on the stock. HC Wainwright also issued estimates for CG Oncology’s Q4 2024 earnings at ($0.36) EPS, FY2024 earnings at ($1.33) EPS, FY2025 earnings at […]

Clene (NASDAQ:CLNN – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They presently have a $31.00 target price on the stock. Other equities analysts have also issued research reports about the company. Canaccord Genuity Group dropped their target price on […]

PDS Biotechnology (NASDAQ:PDSB – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research report issued on Friday,Benzinga reports. They presently have a $21.00 target price on the stock. A number of other research analysts have also recently weighed in on PDSB. Alliance Global Partners raised shares of […]